GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BioArctic AB (OTCPK:BRCTF) » Definitions » 1-Year ROIIC %

BRCTF (BioArctic AB) 1-Year ROIIC % : -72.83% (As of Jun. 2024)


View and export this data going back to 2022. Start your Free Trial

What is BioArctic AB 1-Year ROIIC %?

1-Year Return on Invested Incremental Capital (1-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 1-year. BioArctic AB's 1-Year ROIIC % for the quarter that ended in Jun. 2024 was -72.83%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.

The industry rank for BioArctic AB's 1-Year ROIIC % or its related term are showing as below:

BRCTF's 1-Year ROIIC % is ranked worse than
65.84% of 1417 companies
in the Biotechnology industry
Industry Median: -10.3 vs BRCTF: -72.83

BioArctic AB 1-Year ROIIC % Historical Data

The historical data trend for BioArctic AB's 1-Year ROIIC % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BioArctic AB 1-Year ROIIC % Chart

BioArctic AB Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
1-Year ROIIC %
Get a 7-Day Free Trial Premium Member Only 133.48 468.22 483.31 -288.71 2,789.70

BioArctic AB Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
1-Year ROIIC % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -7,028.13 49.99 2,789.70 -88.56 -72.83

Competitive Comparison of BioArctic AB's 1-Year ROIIC %

For the Biotechnology subindustry, BioArctic AB's 1-Year ROIIC %, along with its competitors' market caps and 1-Year ROIIC % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


BioArctic AB's 1-Year ROIIC % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, BioArctic AB's 1-Year ROIIC % distribution charts can be found below:

* The bar in red indicates where BioArctic AB's 1-Year ROIIC % falls into.



BioArctic AB 1-Year ROIIC % Calculation

BioArctic AB's 1-Year ROIIC % for the quarter that ended in Jun. 2024 is calculated as:

1-Year ROIIC %=1-Year Incremental Net Operating Profit After Taxes (NOPAT)**/1-Year Incremental Invested Capital
=( -12.0512 (Jun. 2024) - 24.6495 (Jun. 2023) )/( 61.247 (Jun. 2024) - 11.362 (Jun. 2023) )
=-36.7007/49.885
=-73.57%***

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** TTM data of NOPAT and Invested Capital was used to calculate 1-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.


BioArctic AB  (OTCPK:BRCTF) 1-Year ROIIC % Explanation

Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.

High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.

Be Aware

It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.


BioArctic AB 1-Year ROIIC % Related Terms

Thank you for viewing the detailed overview of BioArctic AB's 1-Year ROIIC % provided by GuruFocus.com. Please click on the following links to see related term pages.


BioArctic AB Business Description

Traded in Other Exchanges
Address
Warfvinges vag 35, Stockholm, SWE, SE-112 51
BioArctic AB is a research-based biopharmaceutical company focusing on disease-modifying treatments and diagnostics for neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease, and ALS. In addition, the group is also focused on the development of a treatment with a combination of a biodegradable medical device and a drug substance for complete spinal cord injury. Geographically, it derives a majority of its revenue from Asia.

BioArctic AB Headlines

From GuruFocus

Q4 2021 BioArctic AB Earnings Call Transcript

By GuruFocus Research 02-13-2024

Q1 2022 BioArctic AB Earnings Call Transcript

By GuruFocus Research 02-13-2024

BioArctic winner of the Allbright Award 2020

By PRNewswire PRNewswire 10-15-2020

Q2 2019 BioArctic AB Earnings Call Transcript

By GuruFocus Research 02-13-2024

Interim Report for the period January - March 2020

By PRNewswire PRNewswire 04-22-2020

Q1 2021 BioArctic AB Earnings Call Transcript

By GuruFocus Research 02-13-2024

Q3 2021 BioArctic AB Earnings Call Transcript

By GuruFocus Research 02-13-2024